Literature DB >> 21536207

Comparative evaluation of maxillary protraction with or without skeletal anchorage.

Cağla Sar1, Ayça Arman-Özçırpıcı, Sina Uçkan, A Canan Yazıcı.   

Abstract

INTRODUCTION: The aim of this prospective clinical study was to evaluate the skeletal, dentoalveolar, and soft-tissue effects of maxillary protraction with miniplates compared with conventional facemask therapy and an untreated Class III control group.
METHODS: Forty-five subjects who were in prepubertal or pubertal skeletal growth periods were included in the study and divided into 3 groups of 15 patients each. All subjects had skeletal and dental Class III malocclusions with maxillary deficiency, vertically normal growth pattern, anterior crossbite, Angle Class III molar relationship, normal or increased overbite, and retrusive nasomaxillary complex. Before maxillary protraction, rapid maxillary expansion with a bonded appliance was performed in both treatment groups. In the first group (MP+FM), consisting of 5 girls and 10 boys (mean age, 10.91 years), facemasks were applied from 2 titanium miniplates surgically placed laterally to the apertura piriformis regions of the maxilla. The second group (FM) of 7 girls and 8 boys (mean age, 10.31 years) received maxillary protraction therapy with conventional facemasks applied from hooks of the rapid maxillary expansion appliance. The third group of 8 girls and 7 boys (mean age, 10.05 years) was the untreated control group. Lateral cephalometric films were obtained at the beginning and end of treatment or observation in all groups and analyzed according to a structural superimposition method. Measurements were evaulated statistically with Wilcoxon and Kruskal-Wallis tests.
RESULTS: Treatment periods were 6.78 and 9.45 months in the MP+FM and FM groups, respectively, and the observation period in the control group was 7.59 months. The differences were significant between the 3 groups (P <0.05) and the MP+FM and FM groups (P <0.001). The maxilla moved forward for 2.3 mm in the MP+FM group and 1.83 mm in the FM group with maxillary protraction. The difference was significant between 2 groups (P <0.001). The protraction rates were 0.45 mm per month in the MP+FM group and 0.24 mm per month in the FM group (P <0.001). The maxilla showed anterior rotation after facemask therapy in the FM group (P <0.01); there was no significant rotation in the MP+FM group. Posterior rotation of the mandible and increased facial height were more evident in the FM group compared with the MP+FM group (P <0.01). Both the maxilla and the mandible moved forward significantly in the control group. Protrusion and mesialization of the maxillary teeth in the FM group were eliminated in the MP+FM group. The maxillomandibular relationships and the soft-tissue profile were improved remarkably in both treatment groups.
CONCLUSIONS: The undesired effects of conventional facemask therapy were reduced or eliminated with miniplate anchorage, and efficient maxillary protraction was achieved in a shorter treatment period.
Copyright © 2011 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21536207     DOI: 10.1016/j.ajodo.2009.06.039

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  27 in total

1.  Assessing bone volume for orthodontic miniplate fixation below the maxillary frontal process.

Authors:  T M Präger; H G Brochhagen; R Mischkowski; P-G Jost-Brinkmann; R Müller-Hartwich
Journal:  J Orofac Orthop       Date:  2014-08-28       Impact factor: 1.938

2.  Bone-anchored maxillary protraction in patients with unilateral cleft lip and palate.

Authors:  Eman H Elabbassy; Noha E Sabet; Islam T Hassan; Dina H Elghoul; Marwa A Elkassaby
Journal:  Angle Orthod       Date:  2020-07-01       Impact factor: 2.079

3.  Comparison of short-term effects between face mask and skeletal anchorage therapy with intermaxillary elastics in patients with maxillary retrognathia.

Authors:  Cahide Ağlarcı; Elçin Esenlik; Yavuz Fındık
Journal:  Eur J Orthod       Date:  2015-07-27       Impact factor: 3.075

4.  Reverse Forsus vs. facemask/rapid palatal expansion appliances in growing subjects with mild class III malocclusions : A randomized controlled clinical study.

Authors:  Mehmet Ali Yavan; Aysegul Gulec; Metin Orhan
Journal:  J Orofac Orthop       Date:  2021-07-16       Impact factor: 1.938

5.  Dentofacial effects of two facemask therapies for maxillary protraction.

Authors:  Yuan Shu Ge; Jin Liu; Lin Chen; Jian Li Han; Xin Guo
Journal:  Angle Orthod       Date:  2012-05-28       Impact factor: 2.079

Review 6.  Effectiveness of TAD-anchored maxillary protraction in late mixed dentition.

Authors:  Xiaoxia Feng; Jianhua Li; Yu Li; Zhihe Zhao; Sen Zhao; Jue Wang
Journal:  Angle Orthod       Date:  2012-03-29       Impact factor: 2.079

7.  [Meta-analysis of the efficacy of bone anchorage and maxillary facemask protraction devices in treating skeletal class Ⅲ malocclusion in adolescents].

Authors:  Hui Shi; Hong-Shan Ge; Lu-Yi Chen; Zhi-Hua Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-02-01

8.  The short-term treatment effects of face mask therapy in Class III patients based on the anchorage device: miniplates vs rapid maxillary expansion.

Authors:  Nam-Ki Lee; Il-Hyung Yang; Seung-Hak Baek
Journal:  Angle Orthod       Date:  2012-01-20       Impact factor: 2.079

9.  Comparison of skeletal anchored facemask and tooth-borne facemask according to vertical skeletal pattern and growth stage.

Authors:  Sang-Duck Koh; Dong Hwa Chung
Journal:  Angle Orthod       Date:  2013-11-25       Impact factor: 2.079

Review 10.  Bone- and dentoalveolar-anchored dentofacial orthopedics for Class III malocclusion: new approaches, similar objectives? : a systematic review.

Authors:  Marta Morales-Fernández; Alejandro Iglesias-Linares; Rosa Maria Yañez-Vico; Asuncion Mendoza-Mendoza; Enrique Solano-Reina
Journal:  Angle Orthod       Date:  2012-09-26       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.